ArticleCureus2026
Maternal Outcomes and Resource Utilization in Pregnancy-Related Hospitalizations Among Patients With Irritable Bowel Syndrome: A Nationwide Inpatient Analysis, 2020-2022.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Irritable bowel syndrome (IBS) is common among women of reproductive age, yet its implications for pregnancy-related hospitalizations and maternal outcomes in contemporary inpatient settings remain incompletely characterized. Accordingly, this study aimed to address this gap. Methods We performed a retrospective, cross-sectional analysis of delivery-related hospitalizations from 2020 to 2022 using the Nationwide Inpatient Sample (NIS). IBS was identified using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes documented during the delivery hospitalization. Survey-weighted analyses were used to generate nationally representative estimates. Multivariable regression models, adjusted for demographic factors, obstetric characteristics, medical comorbidities, psychiatric conditions, and substance use, were used to evaluate the associations between IBS and maternal outcomes, length of stay, and total hospital charges. Sensitivity analyses examined placenta-specific outcomes and postpartum infections using more granular outcome definitions. Results Among 2,086,607 weighted pregnancy-related hospitalizations, 4,889 (0.23%) had a documented diagnosis of IBS. Patients with IBS were older and had a higher burden of psychiatric, metabolic, and substance-related comorbidities. After multivariable adjustment, IBS was independently associated with prolonged length of stay (adjusted odds ratio (aOR): 1.29, 95% confidence interval (CI): 1.13-1.48), higher hospital charges (adjusted mean increase: $1,656, 95% CI: $769-$2,544), placental complications (aOR: 1.23, 95% CI: 1.08-1.40), and postpartum infection (aOR: 1.41, 95% CI: 1.00-1.98). IBS was not associated with major maternal complications or mortality. Sensitivity analyses demonstrated outcome specificity. Conclusions In this contemporary nationwide inpatient analysis, IBS was infrequently documented during pregnancy-related hospitalizations but was associated with an increased comorbidity burden, resource utilization, and select obstetric complications. These findings suggest that IBS in pregnancy functions as a marker of obstetric complexity rather than a strong independent risk factor for most major maternal complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.